Navigation Links
Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
Date:11/20/2008

CHICAGO, Nov. 20 /PRNewswire/ -- Celsis International plc (LSE: CEL.L), the global leader in rapid microbial detection solutions for industry, today announced the launch of RapiScreen(TM) Beverage, a new assay for use on the Celsis Innovate -- the company's proven rapid microbial screening instrument for dairy products. This new rapid screening test kit extends the Celsis Innovate platform to efficiently and rapidly screen Ultra Heat Treated (UHT) and Extended Shelf Life (ESL) beverage products for microbial contamination.

The flexibility and high-throughput of the Celsis Innovate system makes it ideal for companies that produce beverage and dairy products alike. The RapiScreen Beverage kit works on everything from clear to pulpy juices, from broths to soups, with no filtering necessary.

"Many of our dairy industry customers are expanding their product portfolios to include non-dairy products such as nutritional shakes and fruit- or broth-based items," said Judy Madden, VP of the Celsis Rapid Detection division. "With the addition of the RapiScreen Beverage kit for the Innovate, the same trusted platform now can be used to test for contamination across their entire spectrum of products, quickly and efficiently."

Adenosine Triphosphate (ATP) bioluminescence is the industry standard for the rapid microbial screening of UHT and ESL beverage products. Using proprietary innovations in enzyme technology, RapiScreen Beverage for Innovate delivers reliable and consistent results on a broad range of products in 24-48 hours. Additional benefits include:

    --  Validation available on a wide variety of UHT/ESL beverage products
        including broths, soups, sport drinks, ready-to-drink teas,
        yogurt-based drinks, fruit juices and nutritional supplements
    --  Effective on low pH products
    --  Equally effective with filterable and non-filterable products
    --  Process is non-destructive, allowing for further testing if needed
    --  Validated on a wide range of microorganisms

The Celsis RapiScreen Beverage kit offers a cost-effective, rapid screening solution for the Innovate platform that drives quick results and ROI. Companies interested in learning more about RapiScreen Beverage for the Innovate can visit http://www.celsis.com/rapid for more information.

About Celsis Rapid Detection Systems

By significantly reducing the time required to test and release raw materials, in-process and finished goods, manufacturers using Celsis Rapid Detection systems realize improved cash flow and reduced working-capital requirements, while ensuring quality and increased responsiveness throughout the supply chain. Celsis' extensive client base includes many of the world's leading pharmaceutical and consumer products companies. Founded in the UK and now headquartered in Chicago, the Company has been listed on the London Stock Exchange (CEL.L) since 1993.


'/>"/>
SOURCE Celsis International plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Celsis Receives Frost & Sullivan 2008 Best Practices Award
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Novozymes Launches Enzyme to Reduce Acrylamide in Food
4. Enova Medical Launches Exos Corporation
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. ThirdBiotech Networking Group Launches
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Kingfisher Healthcare Launches Breakthrough Product in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
Breaking Biology Technology:
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
Breaking Biology News(10 mins):